Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells.
Int J Nanomedicine
; 15: 1021-1035, 2020.
Article
in En
| MEDLINE
| ID: mdl-32103954
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cancer Vaccines
/
Nanoparticles
/
Ubiquitinated Proteins
Limits:
Animals
Language:
En
Journal:
Int J Nanomedicine
Year:
2020
Document type:
Article
Country of publication:
New Zealand